In rodents, placental lactogens/prolactins (PL/PRL), growth hormone (GH), and insulin-like growth factor 2 (IGF2) modulate maternal insulin and glucose levels during pregnancy and perturbed expression of these proteins by the placenta have been associated with GDM and abnormal fetal growth in humans. Here, INS is linked to gestational diabetes.